USDA Beltsville Human Nutrition Research Center
Beltsville, Maryland, 20705, United States
NCT Number: NCT01832909
The objective of this study is to measure the energy value of walnuts in the human diet and study molecular mechanisms that may help explain the beneficial health effects of walnuts. The hypothesis is that there will be less metabolizable energy in walnuts due to decreased fat digestibility.
Looking for future studies?
Notify Me25 year–65 year
All sexes
Interventional
Not applicable
Beltsville, Maryland, 20705, United States
Previous studies have demonstrated that nut consumption imparts a variety of health benefits, including reduction of cardiovascular disease and improved satiety. The aim of this study is to determine the energy value of walnuts in the human diet and to probe mechanisms by which walnuts impart health benefits. The metabolizable energy value of walnuts will be calculated based on the chemical composition and energy content of the consumed diet and excreta. This will provide a better estimate of the energy value of walnuts than simply calculating energy value based on Atwater factors. In addition to determining the energy value of walnuts, we will evaluate the effects of walnut-rich diets on plasma phytonutrient levels and on gene expression changes to determine what protective mechanisms are activated by walnut consumption.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Controlled diet with 1.5 oz/d of walnuts.
Controlled diet without walnuts.
Time frame: Each three weeks, up to 6 weeks
Metabolizable energy content will be calculated according to the methods of Novotny et al. (2012). Fat, protein, and fiber digestibility will be calculated and the effect of walnuts on nutrient digestibility will be assessed.
Time frame: At the end of each 3-week intervention period
Gene expression in whole blood will be evaluated through global gene expression using the Affymetrix platform. Changes in specific genes observed with global gene expression technology will be confirmed through reverse transcription polymerase chain reaction.
Time frame: End of each 3-week intervention period
Analysis of markers such as oxidized-low density lipoprotein and inflammatory markers (C-reactive protein, interleukin-1, interleukin-6, tumor necrosis factor-alpha).
Time frame: End of each 3-week intervention period
Blood and urine will be analyzed for appearance of walnut nutrients and their metabolites.
USDA Beltsville Human Nutrition Research Center
Fed
Macronutrient Absorption From Walnuts: The Measured Energy Value of Walnuts in the Human Diet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.